
        <!DOCTYPE html>
                                <html lang="en">
                                <head>
                                <script type="text/javascript"> 
                                function showHideRow(row) { 
                                $("#" + row).toggle(); 
                                } 
                                </script> 
                                <!-- Google tag (gtag.js) -->
                                <script async src="https://www.googletagmanager.com/gtag/js?id=G-Y4QD0XT301"></script>
                                <script>
                                window.dataLayer = window.dataLayer || [];
                                function gtag(){dataLayer.push(arguments);}
                                gtag('js', new Date());
        
                                gtag('config', 'G-Y4QD0XT301');
                                </script>
        
                                
                                <script src=
        "https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js">
                                </script>
                                <link rel="icon" href="./austeritylogosmall.png" type="image/icon type">
                                <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8927651371422323"
                                crossorigin="anonymous"></script>
                                <title>Latest Market News - Austerity Newswire</title>
                              
                                <meta name="description" content="Austerity Newswire tracks the most up-to-date and most influential world market news headlines. Our goal is to provide
                                a dense and reliable flow of live buisness, economic, financial, and geopolitical news."></head>
                                <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no">
                                <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
                                <link rel="stylesheet" type="text/css" href="style2.css" >
                                <link rel="preconnect" href="https://fonts.googleapis.com">
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link href="https://fonts.googleapis.com/css2?family=Dongle&display=swap" rel="stylesheet">
                                <header class='header'>
        
                                <div style='width:100%; height:100%; display:inline-block; text-align:center;'>
                                <script src=
                                "https://ajax.googleapis.com/ajax/libs/jquery/3.4.1/jquery.min.js">
                                </script>
                                <img  class='logo' src="./austeritylogosmall.png">
                                <script> 
$(document).ready(function(){
setInterval(function(){
      $("#live").load(window.location.href + " #live" );
}, 3000);
});
</script>

        
                                <a style = 'color:white''class='cta' href='https://twitter.com/austeritynews'><button>Follow Us</button></a>	
                                <span style = 'font-type:Verdana;float:right;color:#fff;margin:10px;'id="time"></span>
                                 <script type="text/javascript" charset="utf-8">
    let a;
    let time;
    setInterval(() => {
      a = new Date();
      time = a.getHours() + ':' + a.getMinutes() + ':' + a.getSeconds();
      document.getElementById('time').innerHTML = time;
    }, 1000);
  </script>
                                </div>   
        
                                </header>
                                <div style='height:30px;'></div>
                             
        
                                </div>
        
        
        
                                <body>
                                <h1 class='head1'>Feed</h1>

        
        
            <hr class='ider'>    
                </div>
        
        
        
        
        
        
        
        </div>
        
        <div style='overflow-x:auto;'>
        
        <table id ='live' class='sortable'>
        
        
                
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:50:29</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055965-iinx-to-acquire-dalian-huagang-in-strategic-logistics-move?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>IINX to acquire Dalian Huagang in strategic logistics move</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:48:38</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/9019611/processa-pharmaceuticals-to-effect-a-1-for-20-reverse-stock-split' style=' font-size:13px; text-decoration:none;'>Processa Pharmaceuticals to Effect a 1for20 Reverse Stock Split</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:46:46</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055962-canopy-growth-announces-upsized-35-million-private-placement?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Canopy Growth announces upsized $35 million private placement</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:43:08</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/accesswire/825995msn/nextech3dais-breakthrough-ai-powered-search-engine-able-to-deliver-a-500-increase-in-productivity' style=' font-size:13px; text-decoration:none;'>Nextech3D.ai's Breakthrough AI Powered Search Engine Able to Deliver a 500% Increase in Productivity</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:41:18</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055960-perspective-therapeutics-prices-stock-offering-of-600m-and-208m-private-placement?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Perspective Therapeutics prices stock offering of $60.0M and $20.8M private placement</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:39:30</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/biden-north-carolina-internet-election-270a1edc65ebad44cec44baf1f8f4f8b' style=' font-size:13px; text-decoration:none;'>President Joe Biden is going to North Carolina to highlight $82 million in new investments that would connect 16000 households and businesses to highspeed internet.</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:37:38</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055959-wells-fargo-cut-to-hold-at-odeon-as-it-navigates-numerous-industry-challenges?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Wells Fargo cut to Hold at Odeon as it navigates numerous industry challenges</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:37:38</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/9019755/ranchero-announces-execution-of-a-definitive-agreement-related-to-the-disposition-of-its-santa-daniela-property' style=' font-size:13px; text-decoration:none;'>Ranchero Announces Execution of a Definitive Agreement Related to the Disposition of its Santa Daniela Property</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:37:38</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/business-wire/20240118340372/qualitech-names-rick-pedersen-chief-executive-officer' style=' font-size:13px; text-decoration:none;'>QualiTech Names Rick Pedersen Chief Executive Officer</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:34:01</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/18/pakistan-launches-precise-military-strikes-on-iran-in-response-to-bombing' style=' font-size:13px; text-decoration:none;'>Pakistan missiles strike Iran in retaliatory bombing as tensions soar</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:34:00</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055957-caesars-entertainment-issues-preliminary-q4-guidance?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Caesars Entertainment issues preliminary Q4 guidance</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:34:00</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055958-bayer-backs-off-potential-breakup-despite-investor-pressure-bloomberg?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Bayer backs off potential breakup despite investor pressure  Bloomberg</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:32:10</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/18/ukraine-winter-shelling' style=' font-size:13px; text-decoration:none;'>Ukraines harsh winter a memory but new Russian tactics sow destruction</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:32:09</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055954-reddit-plans-to-launch-ipo-in-march-reuters?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Reddit plans to launch IPO in March  Reuters</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:26:43</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/US/suspect-sought-queens-new-york-stabbings/story?id=106455830' style=' font-size:13px; text-decoration:none;'>Suspect arrested in NYC stabbing spree police say</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:21:11</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/9019618/hillevax-announces-executive-management-appointment-of-sean-mcloughlin-as-chief-operating-officer' style=' font-size:13px; text-decoration:none;'>HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:21:11</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/business-wire/20240118372418/takeda-named-global-top-employer-for-seventh-consecutive-year' style=' font-size:13px; text-decoration:none;'>Takeda Named Global Top Employer for Seventh Consecutive Year</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:21:11</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909351/wolters-kluwer-releases-new-service-pack-for-enablon-vision-platform' style=' font-size:13px; text-decoration:none;'>Wolters Kluwer releases new service pack for Enablon Vision Platform</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:21:11</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/marketwatch/20240118214/sam-altman-reveals-his-thoughts-on-openais-executive-shakeup' style=' font-size:13px; text-decoration:none;'>Sam Altman reveals his thoughts on OpenAI's executive shakeup</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:17:32</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/of-all-the-copyright-suits-against-ai-companies-this-one-could-be-the-game-changer-4eb41ffd?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Of all the copyright suits against AI companies this one could be the gamechanger</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:15:43</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/sam-altman-reveals-his-thoughts-on-openais-executive-shakeup-685a8e96?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Sam Altman reveals his thoughts on OpenAIs executive shakeup</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:15:42</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055942-humana-stock-slides-after-cutting-annual-earnings-outlook?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Humana stock slides after cutting profit outlook on higher medical costs</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:11:59</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.wsj.com/articles/chip-giant-tsmc-foresees-delay-at-second-arizona-plant-22fe1e41?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>One of Bidens Favorite Chip Projects Is Facing New Delays</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:10:09</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/vinfast-4q-deliveries-increase-despite-slower-ev-adoption-42039a0c?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>VinFast 4Q Deliveries Increase Despite Slower EV Adoption</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:06:30</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055855-goodyear-tire-set-to-name-stellantis-executive-as-ceo-amid-elliott-push-report?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Goodyear Tire names Stellantis executive as CEO amid Elliott push (update)</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 07:04:41</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055942-humana-stock-slides-after-cutting-annual-earnings-outlook?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Humana stock slides after cutting annual earnings outlook</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:55:36</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055939-birkenstock-falls-after-warning-on-margin-pressures?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Birkenstock falls after warning on margin pressures</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:50:05</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/International/shark-attack-bahamas-resort/story?id=106426143' style=' font-size:13px; text-decoration:none;'>10yearold boy attacked by shark at resort</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:48:14</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/pr-newswire/20240118la15235/vinfast-announces-4q23-deliveries-and-sets-date-for-the-release-of-4q23-results' style=' font-size:13px; text-decoration:none;'>VinFast Announces 4Q23 Deliveries and Sets Date for the Release of 4Q23 Results</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:44:32</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055935-vinfast-auto-falls-short-of-2023-deliveries-target?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>VinFast Auto falls short of 2023 deliveries target</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:37:15</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055934-mainstreetchamber-buys-substantial-equity-interest-in-kathy-ireland-worldwide-categories?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>MainStreetChamber buys substantial equity interest in kathy ireland Worldwide categories</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:26:20</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055929-ceres-signs-first-hydrogen-licence-with-delta?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Ceres signs first hydrogen licence with Delta</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:22:40</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055928-nuvve-holding-announces-1-for-40-reverse-stock-split?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Nuvve Holding announces 1for40 reverse stock split</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:19:02</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/traffic-through-the-panama-canal-is-being-cut-due-to-drought-disrupting-global-trade-ad7669f2?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Traffic through the Panama Canal is being cut due to drought disrupting global trade</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:19:01</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055927-coherent-introduces-1000-mw-red-laser-modules-for-super-resolution-microscopy?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Coherent introduces 1000 mw red laser modules for superresolution microscopy</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:17:13</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/goodyear-names-stellantis-executive-mark-stewart-president-ceo-1c81aed9?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Goodyear Names Stellantis Executive Mark Stewart President CEO</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:13:32</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055926-origin-agritech-announces-appeal-of-nasdaq-delisting-letter?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Origin Agritech announces appeal of Nasdaq delisting letter</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:09:53</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/pr-newswire/20240118la14982/gregg-renfrew-beautycounter-founder-returns-as-chief-executive-officer-to-lead-the-pioneer-in-clean-beauty' style=' font-size:13px; text-decoration:none;'>Gregg Renfrew Beautycounter Founder Returns as Chief Executive Officer to Lead the Pioneer in Clean Beauty</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:06:16</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/treasury-yields-dip-ahead-of-jobless-claims-and-housing-data-306f0cbe?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Treasury yields dip ahead of jobless claims and housing data</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:04:28</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/surgepays-shares-slip-premarket-after-public-offering-c6726f9c?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>SurgePays Shares Slip Premarket After Public Offering</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:04:27</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/pr-newswire/20240118sf13197/figure-announces-commercial-agreement-with-bmw-manufacturing-to-bring-general-purpose-robots-into-automotive-production' style=' font-size:13px; text-decoration:none;'>Figure announces commercial agreement with BMW Manufacturing to bring general purpose robots into automotive production</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 06:02:38</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055918-global-stock-indices-mixed-amid-rate-cut-bets?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Global stock indices mixed amid ratecut bets</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 05:44:26</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055916-sp500-nasdaq-dow-jones-stock-market?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>S&P Nasdaq Dow futures mixed with plenty of premarket data ahead</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 05:31:41</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/accesswire/826074msn/acme-42-gmbh-announces-publication-of-offer-document-for-public-delisting-tender-offer-to-shareholders-of-invision-aktiengesellschaft' style=' font-size:13px; text-decoration:none;'>Acme 42 GmbH Announces Publication of Offer Document for Public Delisting Tender Offer to Shareholders of InVision Aktiengesellschaft</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 05:09:51</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/9019815/fortuna-reports-record-2023-production-of-452-koz-au-eq-and-2024-annual-guidance-of-457-to-497-koz-au-eq' style=' font-size:13px; text-decoration:none;'>Fortuna reports record 2023 production of 452 koz Au Eq and 2024 annual guidance of 457 to 497 koz Au Eq</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 05:08:02</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/oil-demand-growth-slowdown-marks-return-to-prepandemic-trends-iea-says-update-5e26b0b2?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Oildemand growth returning to prepandemic trends IEA says</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 05:08:01</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055898-kyivstar-estimates-95m-hit-to-2024-revenue-from-last-years-cyberattack?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Kyivstar estimates $95M hit to 2024 revenue from December cyberattack</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 04:35:20</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/malaysia-s-klci-index-falls-for-third-day-230c7fda-5cbcd8b0c407?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Malaysia's KLCI index falls for third day</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 04:35:20</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/thai-stocks-tumble-as-set-index-falls-7a213cd5-ab9044bda762?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Thai stocks tumble as SET Index falls</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 04:35:20</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055883-air-lease-announces-pricing-of-public-offering-of-500m-senior-unsecured-medium-term-notes?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Air Lease announces pricing of public offering of $500M senior unsecured mediumterm notes</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 04:31:43</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/national-world-expects-to-deliver-higher-revenue-beat-ebitda-expectations-091b99b8?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>National World Expects to Deliver Higher Revenue Beat Ebitda Expectations</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 04:31:42</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055882-redwood-trust-prices-600-million-of-debt-offering-via-issuance-of-senior-notes?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Redwood Trust prices $60.0 million of debt offering via issuance of senior notes</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 04:31:42</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/pr-newswire/20240118io15177/ifs-announces-winners-of-the-2023-partner-of-the-year-awards' style=' font-size:13px; text-decoration:none;'>IFS announces winners of the 2023 Partner of the Year Awards</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 04:09:56</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055880-cornish-metals-expects-activity-levels-to-remain-high-through-2024?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Cornish Metals expects activity levels to remain high through 2024</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 04:02:39</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 04:00:51</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055878-european-markets-mixed-as-investors-monitor-meeting-in-davos?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>European markets mixed as investors monitor meeting in Davos</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 04:00:50</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:59:02</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:59:02</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909319/kyivstar-completes-preliminary-assessment-of-the-financial-impact-of-the-cyberattack' style=' font-size:13px; text-decoration:none;'>Kyivstar Completes Preliminary Assessment of the Financial Impact of the Cyberattack</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:57:12</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:55:23</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:53:34</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:51:45</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:49:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:48:10</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:46:21</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:44:32</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:42:44</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:40:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/deutsche-entertainment-aktiengesellschaft-plans-relisting-on-frankfurt-stock-exchange-6745c4f9?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Deutsche Entertainment Aktiengesellschaft Plans Relisting on Frankfurt Stock Exchange</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:40:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:39:07</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:37:19</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:37:18</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/pr-newswire/20240118cn15152/ping-an-named-brand-finances-most-valuable-insurance-brand-in-china-for-the-8th-consecutive-year' style=' font-size:13px; text-decoration:none;'>Ping An Named Brand Finance's Most Valuable Insurance Brand in China for the 8th Consecutive Year</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:35:30</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:33:42</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:31:53</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:30:05</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:28:16</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:26:28</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055875-immatics-prices-upsized-stock-offering-to-raise-175-million?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Immatics prices upsized stock offering to raise $175 million</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:26:27</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:24:39</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:22:49</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:21:00</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:19:13</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/travis-perkins-accelerates-restructuring-plans-to-tackle-challenging-market-conditions-6bbc9e57?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Travis Perkins Accelerates Restructuring Plans to Tackle Challenging Market Conditions</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:19:11</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:17:23</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:15:35</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:13:46</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:11:58</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:10:12</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/liveblog/2024/1/18/pakistan-iran-attacks-live-at-least-7-killed-near-irans-southeast-border' style=' font-size:13px; text-decoration:none;'>Iran says at least nine killed in Pakistani strikes near southeast border</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:10:11</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:10:11</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/pr-newswire/20240118la11304/pepromene-bio-inc-announces-complete-remission-of-the-cohort-1-first-patient-treated-for-relapsed-and-refractory-b-cell-acute-lymphoblastic-leukemia-b-all-in-the-phase-1-clinical-trial-of-pmb-ct01-baffr-car-t-cells-at-city-of-hope' style=' font-size:13px; text-decoration:none;'>PeproMene Bio Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory Bcell Acute Lymphoblastic Leukemia (BALL) in the Phase 1 Clinical Trial of PMBCT01 (BAFFRCAR T Cells) at City of Hope</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:08:22</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:06:34</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:04:47</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:04:47</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/business-wire/20240118007139/ev-launches-the-new-group-website-to-mark-its-transformation-journey-and-the-ambition-to-establish-itself-as-an-international-solutions-provider-in-the-industry' style=' font-size:13px; text-decoration:none;'>EV launches the new Group website to mark its transformation journey and the ambition to establish itself as an international solutions provider in the industry.</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:02:59</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 03:01:12</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:59:23</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:57:35</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055867-air-lease-prices-500m-offering?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Air Lease prices $500M offering</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:57:35</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:55:48</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:54:02</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:52:13</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:50:26</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:48:39</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055866-crowdstrike-president-sells-stock-worth-63m?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>CrowdStrike President sells stock worth $6.3M</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:48:39</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:46:50</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:45:02</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:43:15</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:41:26</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:39:38</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:37:52</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/18/us-launches-new-strikes-on-houthi-targets-in-yemen' style=' font-size:13px; text-decoration:none;'>US launches new strikes on Houthi targets in Yemen</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:37:51</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:37:51</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909271/iktos-announces-the-appointment-of-avirup-bose-as-chief-business-officer' style=' font-size:13px; text-decoration:none;'>Iktos announces the appointment of  Avirup Bose as Chief Business Officer</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:36:03</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:34:16</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:32:29</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:30:42</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:28:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:27:06</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:25:18</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:23:31</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:21:45</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:21:45</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/pr-newswire/20240118io15124/invitation-to-electrolux-group-q4-presentation' style=' font-size:13px; text-decoration:none;'>Invitation to Electrolux Group Q4 presentation</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:19:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:18:11</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055862-talos-energy-prices-upsized-stock-offering-to-raise-351-million?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Talos Energy prices upsized stock offering to raise $351 million</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:18:11</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:16:24</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:14:36</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:12:50</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055861-surgepays-drops-7-prices-15m-equity-offering?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>SurgePays drops 7% prices $15M equity offering</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:12:49</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:11:03</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:09:14</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:07:29</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/chip-maker-tsmc-posts-19-fall-in-net-profit-but-edges-pasts-forecasts-1946bdb2?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Chip maker TSMC posts 19% fall in net profit but edges pasts forecasts</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:07:28</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055860-viridian-therapeutics-stock-slides-on-pricing-stock-offering-to-raise-150-million?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Viridian Therapeutics stock slides on pricing stock offering to raise $150 million</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:07:27</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:05:41</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:05:41</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/business-wire/20240117084303/jti-awarded-global-top-employer-for-the-10th-consecutive-year' style=' font-size:13px; text-decoration:none;'>JTI Awarded Global Top Employer for the 10th Consecutive Year</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:03:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:02:07</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 02:00:21</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:58:33</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:56:47</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:55:03</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/Sports/warriors-assistant-coach-dejan-milojevic-dies-heart-attack/story?id=106457880' style=' font-size:13px; text-decoration:none;'>Warriors assistant coach dies of heart attack</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:55:01</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:53:15</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:51:28</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:49:41</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:47:56</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/trump-carroll-defamation-lawsuit-70d4477120399373934253c7e450643e' style=' font-size:13px; text-decoration:none;'>Donald Trump was threatened with expulsion from his Manhattan civil trial after he repeatedly ignored a warning to keep quiet while writer E. Jean Carroll testified that he shattered her reputation after she accused him of sexual abuse.</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:47:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:46:07</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:44:19</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:42:32</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:40:45</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:38:59</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:37:11</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:35:25</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:33:39</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:31:52</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:30:06</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:28:23</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/US/audio-obtained-tupac-shakur-murder-suspects-jailhouse-call/story?id=106468448' style=' font-size:13px; text-decoration:none;'>Audio obtained of Tupac murder suspect's jail call</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:28:20</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:26:34</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/pakistan-launches-precision-military-strikes-on-alleged-militants-inside-iran-b7f8c5fa?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Pakistans precision military strikes on alleged militants inside Iran kill at least 7</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:26:32</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:24:46</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:23:01</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.wsj.com/articles/australia-shares-shaping-for-opening-decline-617cd230?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Nikkei Closes Flat as Pharma Chemical Stocks Weigh</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:23:00</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:21:12</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:19:28</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:17:41</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:15:53</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:14:07</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:12:21</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:10:37</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/18/pakistan-launches-precise-military-strikes-on-iran-in-response-to-bombing' style=' font-size:13px; text-decoration:none;'>Pakistan launches precise military strikes on Iran in response to bombing</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:10:35</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:08:49</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 01:07:02</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/globe-newswire/1000909285/argenx-announces-approval-of-vyvdura-efgartigimod-alfa-and-hyaluronidase-qvfc-injection-for-subcutaneous-use-in-japan-for-generalized-myasthenia-gravis' style=' font-size:13px; text-decoration:none;'>argenx Announces Approval of VYVDURAÂ® (efgartigimod alfa and hyaluronidaseqvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 00:42:14</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/liveblog/2024/1/18/pakistan-iran-attacks-live-at-least-7-killed-near-irans-southeast-border' style=' font-size:13px; text-decoration:none;'>Iran says at least seven killed in Pakistani strikes near southeast border</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 00:36:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/pakistan-launches-precision-military-strikes-on-alleged-militants-inside-iran-b7f8c5fa?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Pakistan launches precision military strikes on alleged militants inside Iran</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 00:24:28</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/Business/wireStory/federal-official-part-blew-off-jetliner-made-malaysia-106468357' style=' font-size:13px; text-decoration:none;'>Part that blew off plane made by Boeing supplier</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 00:12:02</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/2020-census-illinois-california-new-york-city-b75b58d009575b0a776bd36b1131323c' style=' font-size:13px; text-decoration:none;'>Some US states and NYC succeed in getting 2020 census numbers doublechecked and increased</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-18 00:08:27</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/pr-newswire/20240118dc15010/sephora-and-zoetis-recognized-by-catalyst-for-improving-gender-representation-and-advancing-women' style=' font-size:13px; text-decoration:none;'>Sephora and Zoetis Recognized by Catalyst for Improving Gender Representation and Advancing Women</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:59:38</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/asia-stocks-mixed-after-receding-rate-cut-hopes-dampen-wall-street-mood-564aa268?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Asia stocks mixed after receding ratecut hopes dampen Wall Street mood</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:18:50</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/federal-appeals-court-reverses-ordered-removal-of-texass-floating-barrier-in-rio-grande-faffed64?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Federal appeals court reverses ordered removal of Texass floating barrier in Rio Grande</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/US/4-new-species-deep-sea-octopus-discovered-costa/story?id=106437086' style=' font-size:13px; text-decoration:none;'>4 new octopus species discovered near Costa Rica</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/International/wireStory/japan-airlines-gets-woman-president-fatal-plane-collision-106440776' style=' font-size:13px; text-decoration:none;'>Japan Airlines gets first woman president</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/International/wireStory/prosecutor-probing-tv-studio-attack-ecuador-shot-dead-106463835' style=' font-size:13px; text-decoration:none;'>Prosecutor probing TV studio attack is shot dead</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/Business/wireStory/drought-forced-authorities-slash-traffic-panama-canal-disrupting-106468174' style=' font-size:13px; text-decoration:none;'>Drought forces cuts to Panama Canal traffic</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/GMA/Wellness/minnesota-state-troopers-escort-heart-transplant/story?id=106451902' style=' font-size:13px; text-decoration:none;'>State troopers escort heart for transplant</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/US/wireStory/package-mailed-rural-california-elections-office-tested-positive-106462978' style=' font-size:13px; text-decoration:none;'>Package sent to elections office may have fentanyl</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/US/wireStory/severed-hand-found-pocket-man-suspected-killing-woman-106466741' style=' font-size:13px; text-decoration:none;'>Severed hand found in murder suspect's pocket</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://abcnews.go.com/Politics/wireStory/hawaii-lawmakers-open-new-legislative-session-eyes-wildfire-106468659' style=' font-size:13px; text-decoration:none;'>Hawaii lawmakers open wildfire prevention session</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By ABC</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/kenneth-bonawitz-proud-boys-capitol-riot-a5076656e597712a5cb2c8223bab73ea' style=' font-size:13px; text-decoration:none;'>A Florida man who assaulted at least six police officers during a mobs attack on the U.S. Capitol has been sentenced to five years in prison.</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/supreme-court-abortion-medical-emergencies-idaho-8ca89d7de0c1fa9256dcd27d1847e144' style=' font-size:13px; text-decoration:none;'>The Supreme Court is allowing Idaho to enforce its strict abortion ban even in medical emergencies</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/supreme-court-regulations-environment-herring-fish-chevron-3ccc7cde83f9e6a4ea570e8b1d362077' style=' font-size:13px; text-decoration:none;'>A little fish at the Supreme Court could take a big bite out of regulatory power</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/supreme-court-apple-epic-fortnite-antitrust-iphone-c412553d88f8798acd7d5e1cbb5826bc' style=' font-size:13px; text-decoration:none;'>Supreme Court rebuffs Apples appeal on app payments threatening billions in revenue</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/supreme-court-chevron-regulations-environment-fish-e0c83212c892887860f7800c1ae1e02b' style=' font-size:13px; text-decoration:none;'>The Supreme Court wrestles with major challenges to the power of federal regulators</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/congress-shutdown-speaker-johnson-freedom-caucus-a9683a7381563499e0ba10987e93fb92' style=' font-size:13px; text-decoration:none;'>Speaker Johnson insists hes sticking to budget deal but announces no plan to stop partial shutdown</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/yellen-biden-covid19-american-rescue-plan-5987eaca5c3e6ce5d0638fed5314ec4a' style=' font-size:13px; text-decoration:none;'>Yellen says current US economic growth vindicates Bidens COVID19 pandemic stimulus spending</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/yemen-houthis-global-shipping-attacks-terrorist-designation-d921fe171e5038c791dcd62442948dad' style=' font-size:13px; text-decoration:none;'>US pledges new sanctions over Houthi attacks will minimize harm to Yemens hungry millions</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/election-2024-trump-maine-ballot-supreme-court-7614630adae92bbe0cd7ee3da4d05a19' style=' font-size:13px; text-decoration:none;'>Maine judge delays decision on removing Trump from ballot until Supreme Court rules in Colorado case</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/kamala-harris-donald-trump-2024-c97d14782ff78591486305e5b5a379de' style=' font-size:13px; text-decoration:none;'>Vice President Harris says shes scared as heck that Donald Trump could win</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:57</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://apnews.com/article/trump-carroll-defamation-lawsuit-70d4477120399373934253c7e450643e' style=' font-size:13px; text-decoration:none;'>Judge threatens to boot Donald Trump from courtroom over loud talking as E. Jean Carroll testifies</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AP</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:56</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/16/malta-flagged-cargo-ship-hit-by-missile-in-red-sea' style=' font-size:13px; text-decoration:none;'>Yemens Houthis claim attack on ship in Red Sea as US confirms new strike</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:56</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/17/us-federal-workers-risk-livelihoods-in-push-for-course-change-on-gaza-war' style=' font-size:13px; text-decoration:none;'>US federal workers risk livelihoods in push for course change on Gaza war</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:56</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/17/iran-says-attack-in-pakistan-targeted-iranian-terrorist-group' style=' font-size:13px; text-decoration:none;'>Iran says attack in Pakistan targeted Iranian terrorist group</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:56</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/spirit-airlines-odds-on-its-own-look-shaky-after-judge-blocks-jetblue-merger-fitch-says-035a8c75?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Spirit Airlines odds on its own look shaky after judge blocks JetBlue merger Fitch says</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:56</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/chevron-case-could-see-supreme-court-sharply-curtail-power-of-federal-regulators-4adf0dd2?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Chevron case could see Supreme Court sharply curtail power of federal regulators</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:56</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/tesla-could-be-staring-down-a-year-of-growing-pains-analyst-cautions-4c6c5fde?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Tesla could be staring down a year of growing pains analyst cautions</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:56</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.marketwatch.com/story/feds-beige-book-finds-signs-of-cooling-labor-market-across-most-of-the-country-888d0706?mod=newsviewer_click' style=' font-size:13px; text-decoration:none;'>Feds Beige Book finds signs of cooling labor market across most of the country</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MarketWatch</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/17/deal' style=' font-size:13px; text-decoration:none;'>Aid headed into Gaza after IsraelHamas seal first deal since truce ended</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/17/ukraine-says-controlling-skies-priority-in-war-against-russia' style=' font-size:13px; text-decoration:none;'>Ukraine says controlling skies priority in war against Russia</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/17/death-threats-for-a-stalin-vandal-prompt-soul-searching-in-orthodox-georgia' style=' font-size:13px; text-decoration:none;'>Death threats for a Stalin vandal prompt soulsearching in Orthodox Georgia</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055830-fluence-surpasses-20-gwh-of-deployed-and-contracted-battery-based-energy-storage-systems?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Fluence surpasses 20 GWh of deployed and contracted batterybased energy storage systems</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055831-quantum-submits-plan-to-regain-compliance-with-nasdaq-listing-rules?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Quantum submits plan to regain compliance with Nasdaq listing rules</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055832-us-crude-stockpiles-rose-483k-barrels-last-week-api-says?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>U.S. crude stockpiles rose 483K barrels last week API says</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055835-nasdaq-us-matched-equity-volume-climbs-86-in-december?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Nasdaq U.S. matched equity volume climbs 8.6% in December</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055637-notable-earnings-after-thursdays-close?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Notable earnings after Thursday's close</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055837-statehouse-announces-departure-of-roy-pottle-from-its-board-of-directors?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>StateHouse announces departure of Roy Pottle from its board of directors</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055841-bhp-quarterly-iron-ore-output-edges-lower-will-evaluate-nickel-operations?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>BHP quarterly iron ore output edges lower will evaluate nickel operations</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055842-ngl-energy-partners-announces-700m-senior-secured-term-loan-facility?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>NGL Energy Partners announces $700M senior secured term loan facility</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055848-opec-sees-continued-strong-oil-demand-growth-in-first-forecast-for-2025?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>OPEC sees continued strong oil demand growth in first forecast for 2025</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055851-petrobras-plans-early-2025-finish-for-abreu-e-lima-refinery-train-1-expansion?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Petrobras plans early 2025 finish for Abreu e Lima refinery Train 1 expansion</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055852-us-finalizes-11b-in-aid-to-keep-open-californias-last-nuclear-power-plant?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>U.S. finalizes $1.1B in aid to keep open California's last nuclear power plant</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055853-alcoa-tilts-lower-after-mixed-q4-sees-higher-aluminum-production-this-year?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Alcoa tilts lower after mixed Q4 sees higher aluminum production this year</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055854-textron-is-key-aerospace-stock-going-into-earnings-goldman-sachs-says?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Textron is key aerospace stock going into earnings Goldman Sachs says</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:55</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://seekingalpha.com/news/4055855-goodyear-tire-set-to-name-stellantis-executive-as-ceo-amid-elliott-push-report?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain' style=' font-size:13px; text-decoration:none;'>Goodyear Tire set to name Stellantis executive as CEO amid Elliott push  report</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By SeekingAlpha</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.morningstar.com/news/pr-newswire/20240117la14940/if-you-were-overcharged-for-certain-multi-family-dwelling-recycling-services-in-oakland-between-july-1-2015-and-december-31-2021-you-may-be-eligible-to-receive-a-refund-payment-from-a-settlement' style=' font-size:13px; text-decoration:none;'>If you were overcharged for certain multifamily dwelling recycling services in Oakland between July 1 2015 and December 31 2021 you may be eligible to receive a refund payment from a settlement.</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By MorningStar</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/13/world-reacts-to-taiwan-election-as-china-says-reunification' style=' font-size:13px; text-decoration:none;'>World reacts to Taiwan election as China says reunification inevitable</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/13/taiwan-ruling-partys-lai-wins-presidential-election' style=' font-size:13px; text-decoration:none;'>Taiwan ruling partys Lai wins presidential election</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/15/north-korea-says-it-tested-solid-fuel-missile-with-hypersonic-warhead' style=' font-size:13px; text-decoration:none;'>North Korea says it tested solidfuel missile with hypersonic warhead</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/15/philippines-to-upgrade-outposts-in-disputed-south-china-sea-for-its-troops' style=' font-size:13px; text-decoration:none;'>Philippines plans military upgrades to disputed South China Sea outposts</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/17/malaysia-charges-two-with-wounding-religious-feelings-in-now-banned-film' style=' font-size:13px; text-decoration:none;'>Malaysia charges two with wounding religious feelings in nowbanned film</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    
                
                
                
                
                
              
                
                
            
                
                <tr>
                <td style=' border-right:1px solid grey;width:6%;'><p style ='font-family:arial;text-align:left; font-size:13px; color:grey;'>01-17 23:02:54</p></td>
                
                    <td style='width:75%;'><p style='text-align:left;margin-left:5px;'><a href='https://www.aljazeera.com/news/2024/1/17/two-malaysians-in-guantanamo-plead-guilty-to-conspiring-in-bali-bombings' style=' font-size:13px; text-decoration:none;'>Two Malaysians in Guantanamo plead guilty to conspiring in Bali Bombings</a></p></td>
                    <td style='width:19%;'><p style ='font-family:arial;text-align:right; font-size:13px; color:grey;'>Provided By AJMN</p></td>
                
                </tr>
               
                
                
                
                
                                    


                                        </tbody>



                                        </table>
                        <div style='position: fixed;
  left: 0;
  bottom: 0;
  width: 100%;

  background-color: #13141a;
  color: grey;
  text-align:center;
  font-size:10px;
  display:table;
  vertical-align:middle;
'
  >
                        <p>© Copyright 2024 Austerity.News </p>
                        </div>

                </html>

                